Allergan (AGN): Consensus Is Too High, Cutting PT - Mizuho

November 1, 2016 6:41 AM EDT
Get Alerts AGN Hot Sheet
Price: $214.58 -0.91%

Rating Summary:
    18 Buy, 13 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade AGN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mizuho Securities analyst, Irina Koffler, reiterated her Buy rating on shares of Allergen (NYSE: AGN) but cut her price target to $293 from $299 ahead of 3Q16 earnings. The analyst is cutting her product estimates to incorporate feedback since the last note and to update the model for the latest M&A and regulatory developments.

The analyst thinks consensus estimates are too high. The company will announce earnings on November 2.

For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.

Shares of Allergen closed at $208.94 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Earnings, Irina Koffler

Add Your Comment